Botanix Pharmaceuticals Limited (ASX: BOT)
Australia
· Delayed Price · Currency is AUD 0.320
+0.005 (1.59%)
Nov 22, 2024, 4:10 PM AEST
Botanix Pharmaceuticals Revenue
In the fiscal year ending June 30, 2024, Botanix Pharmaceuticals had annual revenue of 2.07M AUD, down -45.14%. Botanix Pharmaceuticals had revenue of 1.69M in the half year ending June 30, 2024, a decrease of -38.60%.
Revenue
2.07M
Revenue Growth
-45.14%
P/S Ratio
232.22
Revenue / Employee
188.14K
Employees
11
Market Cap
581.59M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 22.18B |
| ResMed Inc. | 6.93B |
| Pro Medicus Limited | 161.50M |
| Fisher & Paykel Healthcare Corporation Limited | 1.60B |
| Cochlear Limited | 2.24B |
| Sonic Healthcare Limited | 8.97B |
| Ramsay Health Care Limited | 16.66B |
| Telix Pharmaceuticals Limited | 645.68M |